Shares in Qiagen rose more than 5 percent on Friday as traders cited market talk that French drug specialist Sanofi-Aventis was considering a bid for the German Biotech.
May 22, 2009...12:51 pm
Sanofi-Aventis potential bid for Quiagen
Jump to Comments
